发明授权
US08648068B2 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions
有权
用于药物组合物的含杂环烷基的噻吩并嘧啶
- 专利标题： Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions
- 专利标题（中）： 用于药物组合物的含杂环烷基的噻吩并嘧啶
-
申请号： US13034913申请日： 2011-02-25
-
公开(公告)号： US08648068B2公开(公告)日： 2014-02-11
- 发明人: Thorsten Lehmann-Lintz , Joerg Kley , Norbert Redemann , Achim Sauer , Leo Thomas , Dieter Wiedenmayer , Matthias Austen , John Danilewicz , Martin Schneider , Kay Schreiter , Phillip Black , Wesley Blackaby , Ian Linney
- 申请人： Thorsten Lehmann-Lintz , Joerg Kley , Norbert Redemann , Achim Sauer , Leo Thomas , Dieter Wiedenmayer , Matthias Austen , John Danilewicz , Martin Schneider , Kay Schreiter , Phillip Black , Wesley Blackaby , Ian Linney
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Edward S. Lazer
- 优先权： EP10154925 20100226
- 主分类号： C07D495/04
- IPC分类号： C07D495/04 ; A61K31/519 ; A61K31/5355 ; A61P35/00 ; A61P25/28 ; A61P3/10
摘要：
The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
公开/授权文献
信息查询
